Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss doesn't affect COVID-19 severity.

There's no significant genetic link between male pattern baldness and COVID-19.

PHAT may improve hair growth better than PRP alone.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.